This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Biwang Jiang: Innovator in Pharmaceutical Purification
Introduction
Biwang Jiang is a notable inventor based in Xinchang County, China. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of important compounds. His innovative methods have the potential to enhance the quality and efficacy of pharmaceutical products.
Latest Patents
Biwang Jiang holds a patent for a "Separation and purification method for vancomycin hydrochloride of high purity." This method involves several steps, including obtaining a vancomycin hydrochloride solution from a crude product through ion exchange chromatography. The process continues with nanofiltration desalination and concentration, followed by column chromatography and further purification steps. Ultimately, this method yields a vancomycin dry powder with a chromatographic purity of up to 99% and a pure white appearance.
Career Highlights
Biwang Jiang is currently employed at Zhejiang Medicine Co., Ltd., specifically at the Xinchang Pharmaceutical Factory. His work focuses on developing advanced purification techniques that are crucial for the pharmaceutical industry. His expertise in this area has positioned him as a valuable asset to his company.
Collaborations
Biwang Jiang collaborates with talented coworkers, including Enmin Li and Yiyun Zhuang. Together, they contribute to the innovative projects at their pharmaceutical facility, enhancing the overall research and development efforts.
Conclusion
Biwang Jiang's contributions to pharmaceutical purification exemplify the importance of innovation in the industry. His patented methods not only improve the quality of vancomycin hydrochloride but also reflect his commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile